NanoDimension

Redwood City, California
NanoDimension is a leading venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences. We focus on early stage opportunities in the US and Europe led by exceptional entrepreneurs. NanoDimension’s investment team takes an active approach to building portfolio companies, leveraging ourexpertise and network to find and build companies with innovative solutions to critical global problems.
Founded:2003
Firm Location:Redwood City, California • Mountain View, California • Menlo Park, California • Geneva • San Francisco Bay Area • United Kingdom • Switzerland
NanoDimension Team
Photo of Dani Bach, Partner at NanoDimension
Dani Bach
NanoDimension·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Geneva
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Pre-seed)
Photo of Klaus Dugi, Venture Partner at NanoDimension
Klaus Dugi
NanoDimension·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Photo of Gabriela Ecco, Associate at NanoDimension
Gabriela Ecco
NanoDimension·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Photo of Kirill Kuzmichev, Principal at NanoDimension
Kirill Kuzmichev
NanoDimension·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Photo of Eric Moessinger, Partner at NanoDimension
Eric Moessinger
NanoDimension·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA), Investors in Redwood City (CA)
Photo of Alison Palmer, Vice President at NanoDimension
Alison Palmer
NanoDimension·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Photo of Aditya Rajagopal, Venture Partner at NanoDimension
Aditya Rajagopal
NanoDimension·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Mountain View (CA)
Photo of Aymeric Sallin, Investor at NanoDimension
Aymeric Sallin
NanoDimension·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Menlo Park (CA)
Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in AI (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Health IT (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)